Successful reintroduction of previously failed ACE inhibitor therapy following stenting of atherosclerotic renovascular disease.


BACKGROUND Angiotensin Converting Enzyme (ACE) inhibitors improve outcomes in patients with coronary artery disease irrespective of the status of the left ventricle. In the presence of functionally significant renovascular disease, ACE inhibitors often cause deterioration of renal function leading to their withdrawal. DESIGN Observational study with 6… (More)